TCTMD

Extended DANISH Follow-up Supports ICD Benefits in Younger Nonischemic HF Patients

Longer-term results of the DANISH trial confirm what was seen 4 years earlier: an implantable cardioverter-defibrillator (ICD) does not reduce the risk of all-cause or CV mortality in patients with ...
TCTMD

ICD Benefits Hold Up for Modern-day Primary Prevention, but Questions Remain

Use of implantable cardioverter-defibrillators (ICDs) for primary prevention of sudden cardiac death appears to be beneficial on the background of modern heart failure (HF) therapies, according to an ...
Hosted on MSN

Hypertrophic cardiomyopathy (HCM) and implantable devices: What to know about ICDs (and other options)

If you have hypertrophic cardiomyopathy (HCM), and especially if you have obstructive HCM that reduces blood flow out of your heart, you and your doctor may discuss ways to lower your risk of sudden ...
Healio

Subcutaneous ICD reduces rate of major lead-related complications: ATLAS

Please provide your email address to receive an email when new articles are posted on . Among patients who received implantable cardioverter defibrillator therapy, a subcutaneous vs. transvenous ...
Healio

For older adults, similar outcomes for subcutaneous vs. transvenous ICDs

Please provide your email address to receive an email when new articles are posted on . “Prior research has established the subcutaneous ICD as a reasonable alternative to the transvenous ICD in ...